Abstract
The crystal structure of human carbonic anhydrase II (CA II) complexed with the inhibitor acetazolamide (AZM) has been determined at 1.1 Å resolution and refined to an R cryst of 11.2% and an R free of 14.7%. As observed in previous CA II-inhibitor complexes, AZM binds directly to the zinc and makes several key interactions with active-site residues. The high-resolution data also showed a glycerol molecule adjacent to the AZM in the active site and two additional AZMs that are adventitiously bound on the surface of the enzyme. The co-binding of AZM and glycerol in the active site demonstrate that given an appropriate ring orientation and substituents, an isozyme-specific CA inhibitor may be developed. © 2009 International Union of Crystallography. All rights reserved.
Author supplied keywords
Cite
CITATION STYLE
Sippel, K. H., Robbins, A. H., Domsic, J., Genis, C., Agbandje-Mckenna, M., & McKenna, R. (2009). High-resolution structure of human carbonic anhydrase II complexed with acetazolamide reveals insights into inhibitor drug design. Acta Crystallographica Section F: Structural Biology and Crystallization Communications, 65(10), 992–995. https://doi.org/10.1107/S1744309109036665
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.